WaldoOakes4 at 10:39, 25 March 2026

2026-03-25T10:39:32Z

New page

{{Short description|Indian academic, researcher}}
{{Infobox academic
| honorific_prefix = Professor
| name = Khurshid Iqbal Andrabi
| image = Khurshid Iqbal Andrabi.jpg
| caption = Official portrait
| birth_date = {{birth date and age|1963|07|15|df=y}}
| birth_place = [[Jammu and Kashmir (state)|Jammu and Kashmir]], India
| occupation = Professor of Biotechnology
| era = Late 20th century – 21st century
| discipline = Biotechnology, Biochemistry
| sub_discipline = [[Cell signalling]], cancer biology, diabetes research
| workplaces = [[University of Kashmir]]
| alma_mater = [[Postgraduate Institute of Medical Education and Research]], [[Chandigarh]]
| thesis_title =
| thesis_year =
| doctoral_advisor =
| academic_advisors =
| doctoral_students =
| notable_students =
| main_interests = [[mTORC1]], [[cell signalling]], translation control, stress responses, cancer and diabetes biology
| known_for =
| notable_works =
| awards =
| title = [[Vice-chancellor]], [[University of Kashmir]] (2014–2018)
| website =
}}

'''Khurshid Iqbal Andrabi''' (born 15 July 1963) is a Kashmiri academic, researcher, and former administrator who served as the [[List of vice chancellors of the University of Kashmir|19th]] [[vice-chancellor]] of the [[University of Kashmir]] from 2014 to 2018. He is a professor in the Department of Biotechnology at the same university and a researcher in the field of [[cell signaling]], with particular contributions to the study of the [[mTORC1]] pathway and its role in cancer, diabetes, and aging.

== Early life and education ==
Andrabi was born to Syed Habibullah Andrabi on 15 July 1963 in [[Srinagar]], [[Jammu and Kashmir (state)|Jammu and Kashmir]], India.<ref name="i500">{{cite web | url=https://kashmiruniversity.net/Diqa/Resume/andrabik.pdf | title= Curriculum Vitae, Khurshid Iqbal Andrabi |access-date=2025-08-16}}</ref><ref name="b239">{{cite web | title=KU Vice Chancellor bereaved | website=Kashmir Observer | date=2018-01-04 | url=https://kashmirobserver.net/2018/01/04/ku-vice-chancellor-bereaved/ | access-date=2025-08-16}}</ref> He completed his master's degree in [[Biochemistry]] at the [[Postgraduate Institute of Medical Education and Research]] (PGIMER), [[Chandigarh]] in 1985, where he was awarded a gold medal and distinction. He went on to obtain a PhD in Biochemistry from PGIMER in 1990.<ref name="i500"/>

== Career ==
Following his doctoral studies, Andrabi pursued postdoctoral research at several institutions, including [[Tufts University School of Medicine]], Boston (1991–1992), [[Harvard Medical School]] - [[Massachusetts General Hospital]] (1992–1996), where he worked on insulin receptor signaling in collaboration with Nobel Laureate [[Edwin G. Krebs]]. He served as assistant professor of Ophthalmic Research at [[Cleveland Clinic Foundation]], USA (1999–2000).<ref name="g154">{{cite web | last=Irfan | first=Shams | title=Dr Khursheed Iqbal Andrabi | website=Kashmir Life | date=2014-10-23 | url=https://kashmirlife.net/dr-khursheed-iqbal-andrabi-66969/ | access-date=2025-08-16}}</ref>

On returning to India, he joined the University of Kashmir as faculty, where he played a pioneering role in establishing the Department of Biotechnology in 2003. The department later gained national recognition under the Department of Biotechnology (DBT).<ref name="i500"/> Prior to his appointment as vice-chancellor, he served as a director, research at the same university.<ref name="o050">{{cite web | title=Prof. (Dr.) Khurshid Iqbal Andrabi appointed Vice Chancellor of Kashmir University | website=Scoop News Jammu Kashmir | date=2025-08-16 | url=https://www.scoopnews.in/det.aspx?q=41674 | access-date=2025-08-16}}</ref>

He has supervised more than 25 doctoral and 20 MPhil students, published over 85 research papers.<ref name="i500"/>
=== Academic administration ===
Andrabi has held several administrative positions at the University of Kashmir such as [[Dean (education)|dean]] from 2012 to 2014, head, Department of Biotechnology (2003–2012), and Department of Biochemistry from 1997 to 2003.<ref name="i500"/>
=== Membership ===
Andrabi has been associated with several academic and professional bodies. He has served on the Board of Award Nominators for Infosys India and on the Board of Advisors for Knimbus India. He has also held editorial positions, including membership of the editorial boards of the [[International Journal of Case Reports in Medicine]], United States and the Asian Journal of Biosciences, India. In addition, he has been a reviewer for several international journals such as Cellular and Molecular Biochemistry, [[Springer, New Mexico]], the [[Austin Journal of Biotechnology & Bioengineering]], USA, Mutation Research, USA, the International Journal of Cellular Biochemistry (USA), and Biochemistry (USA).<ref name="i500"/>

Within academic bodies, Andrabi has been a member of the Indo-Australian Higher Education Commission and the [[British Council for Higher Education]]. In India, he has served as a member of the [[University Grants Commission (India)|University Grants Commission]] (UGC) Peer Team, and has contributed to the Project Advisory Boards of both the UGC and the Department of Science and Technology (DST).<ref name="i500"/>

== Research ==
Andrabi's research focuses on cell signaling, especially the [[mTORC1]] pathway and its downstream effectors such as [[S6K1]] and [[4EBP1]]. His work has provided new insights into the regulation of these [[kinases]], mechanisms of translation control, and implications in cancer, diabetes, and aging.<ref name="i500"/>

He has also investigated the molecular mechanisms of inhibitors like [[rapamycin]] and torin, offering alternate perspectives beyond classical kinase activity. His research also contributed to translational medicine, including [[immunotherapy]] and [[stress response]] in cancer biology.<ref name="i500"/>

== Controversies ==
Andrabi is accused of "illegal appointments" during his tenure as vice-chancellor following which he was removed from the position. He was subsequently appointed as dean at School of Unani & Ayurvedic Medicines and head of department of Bio-chemistry, University of Kashmir.<ref name="g759">{{cite web | title=Ex-VC Kashmir University Removed From Two Key Posts | website=Kashmir Observer | date=2020-01-18 | url=https://kashmirobserver.net/2020/01/18/ex-vc-kashmir-university-removed-from-two-key-posts/ | access-date=2025-08-16}}</ref> Later in 2018, the [[Jammu and Kashmir State Vigilance Commission]] (JKSVC) filed a case against Andrabi's alleged role in nominating ineligible candidate for the post of medical officer at [[SMHS Hospital]], [[Srinagar]].<ref name="u741">{{cite web | title=Vigilance files case against Vice Chancellor of Kashmir University, officials for violating norms | website=Free Press Kashmir | date=2018-03-03 | url=https://freepresskashmir.news/2018/03/03/vigilance-files-case-against-vice-chancellor-of-kashmir-university-officials-for-violating-norms/ | access-date=2025-08-16}}</ref>

== Awards and recognition ==
* Sanofi Award (2017): Best original research in diabetes, [[Research Society for the Study of Diabetes in India]] (RSSDI).
* Young Scientist Award (1998): Department of Science & Technology, Kashmir.
* Certificates of Excellence in Teaching (2006, 2019): [[Kashmir University]]
* Most Downloaded Paper Award (2019): ''[[Journal of Cellular Biochemistry]]''
* Certificate of Merit for Excellent Overall Performance (2007-08): University of Kashmir
* NET-JRF Fellowship (1986): [[Council of Scientific and Industrial Research]].
* Gold Medal in MSc Biochemistry (1985) at [[PGIMER]], Chandigarh.<ref name="i500"/>

== Publications ==
=== Book chapters ===
* {{cite book |last1=Ali |first1=S. |last2=Afroze |first2=D. |last3=Rasool |first3=J. |last4=Rah |first4=B. |last5=Andrabi |first5=K. I. |year=2020 |title=Immunomodulating agents in the treatment of acute myeloid leukemia: A combinatorial immunotherapeutic approach |chapter=Frontiers in Clinical Drug Research – Anti-Cancer Agents |pages=1–22 |publisher=Bentham Science Publishers}}
* {{cite book |last1=Majeed |first1=S. T. |last2=Majeed |first2=R. |last3=Shah |first3=G. |last4=Andrabi |first4=K. I. |date=2018-11-05 |title=S6 Kinase: A Compelling Prospect for Therapeutic Interventions |chapter=Homeostasis – An Integrated Vision |editor1-last=Lasakosvitsch |editor1-first=Fernanda |editor2-last=Dos Anjos Garnes |editor2-first=Sergio |publisher=IntechOpen}}
* {{cite book |last1=Mudassar |first1=S. |last2=Khan |first2=M. S. |last3=Masoodi |first3=S. R. |last4=Wani |first4=K. A. |last5=Hussain |first5=M. U. |last6=Andrabi |first6=K. I. |year=2016 |title=Molecular Alterations and Expression Dynamics in the Etiopathogenesis of Thyroid Cancer |chapter=Thyroid Cancer – Advances in Diagnosis and Therapy |publisher=IntechOpen}}
* {{cite book |last1=Prabhu |first1=P. S. |last2=Patravale |first2=P. B. |last3=Andrabi |first3=K. I. |last4=Sheikh |first4=F. A. |year=2016 |title=Nanotherapeutics: Future medicine for infectious diseases |chapter=Frontiers in Drug Design and Discovery |volume=7 |pages=248–297 |publisher=Bentham Science Publishers}}
* {{cite book |last1=S. |first1= |last2=Khan |first2=M. S. |last3=Khan |first3=N. P. |last4=Hussain |first4=M. U. |last5=Andrabi |first5=K. I. |year=2014 |title=Possible Role of Proto-Oncogenes in Colorectal Cancer — A Population Based Study |chapter=Colorectal Cancer – Surgery, Diagnostics and Treatment |editor-last=Khan |editor-first=Jim S. |publisher=IntechOpen |isbn=978-953-51-1231-0}}
=== Reviews ===
* {{cite journal |last1=Batool |first1=A. |last2=Malik |first2=F. |last3=Andrabi |first3=K. I. |year=2020 |title=Expansion of the CRISPR/Cas genome-sculpting toolbox: Innovations, applications and challenges |journal=Molecular Diagnosis and Therapy}}
* {{cite journal |last1=Batool |first1=A. |last2=Aashaq |first2=S. |last3=Andrabi |first3=K. I. |year=2019 |title=Eukaryotic initiation factor 4E (eIF4E): A recap of the cap binding protein |journal=Journal of Cellular Biochemistry}}
* {{cite journal |last1=Aashaq |first1=S. |last2=Batool |first2=A. |last3=Andrabi |first3=K. I. |year=2019 |title=TAK1 mediates convergence of cellular signals for death and survival |journal=Apoptosis |volume=24 |issue=1–2 |pages=3–20}}
* {{cite journal |last1=Raja |first1=V. |last2=Majeed |first2=U. |last3=Kang |first3=H. |last4=Andrabi |first4=K. I. |last5=John |first5=R. |year=2017 |title=Abiotic stress: Interplay between ROS, hormones and MAPKs |journal=Environmental and Experimental Botany}}
* {{cite journal |last1=Batool |first1=A. |last2=Aashaq |first2=S. |last3=Andrabi |first3=K. I. |year=2017 |title=Reappraisal to the study of 4E-BP1 as an mTOR substrate – A normative critique |journal=European Journal of Cell Biology |volume=96 |issue=4 |pages=325–336}}
* {{cite journal |last1=Shiekh |first1=F. A. |last2=Farooq |first2=O. |last3=Mian |first3=S. H. |last4=Bautista |first4=R. L. |last5=Arja |first5=S. B. |last6=Andrabi |first6=K. I. |year=2016 |title=The pitfalls of growing nanomaterials |journal=Nanomedicine (London) |volume=11 |issue=13 |pages=1635–1638}}
=== Selected articles ===
* {{cite journal | last1=Majeed | first1=Sheikh Tahir | last2=Batool | first2=Asiya | last3=Majeed | first3=Rabiya | last4=Bhat | first4=Nadiem Nazir | last5=Zargar | first5=Muhammad Afzal | last6=Andrabi | first6=Khurshid Iqbal | title=mTORC1 induces eukaryotic translation initiation factor 4E interaction with TOS-S6 kinase 1 and its activation | journal=Cell Cycle | publisher=Informa UK Limited | volume=20 | issue=9 | date=2021-05-03 | issn=1538-4101 | doi=10.1080/15384101.2021.1901038 | doi-access=free | pages=839–854 | url=https://www.tandfonline.com/doi/pdf/10.1080/15384101.2021.1901038?needAccess=true | access-date=2025-08-16| pmc=8168643 }}
* {{cite journal | last1=Beigh | first1=Afaq H. | last2=Rasool | first2=Roohi | last3=Kawoosa | first3=Fizalah | last4=manzoor | first4=Sharika | last5=Rashid | first5=Rabiya | last6=Andrabi | first6=Khurshid Iqbal | last7=shah | first7=Zafar A. | last8=Qureshi | first8=Taha | title=Improved pulmonary function test (PFT) after 1 one year of Sublingual Immunotherapy (SLIT) in unison with pharmacotherapy in mild allergic asthmatics | journal=Immunology Letters | publisher=Elsevier BV | volume=230 | year=2021 | issn=0165-2478 | doi=10.1016/j.imlet.2020.12.004 | pages=36–41}}
* {{cite journal | last1=Aashaq | first1=Sabreena | last2=Batool | first2=Asiya | last3=Andrabi | first3=Khurshid I. | title=TAK1 mediates convergence of cellular signals for death and survival | journal=Apoptosis | publisher=Springer Science and Business Media LLC | volume=24 | issue=1-2 | date=2018-10-04 | issn=1360-8185 | doi=10.1007/s10495-018-1490-7 | pages=3–20}}
* {{cite journal | last1=Batool | first1=Asiya | last2=Majeed | first2=Sheikh Tahir | last3=Aashaq | first3=Sabreena | last4=Majeed | first4=Rabiya | last5=Bhat | first5=Nadiem Nazir | last6=Andrabi | first6=Khurshid Iqbal | title=Eukaryotic initiation factor 4E is a novel effector of mTORC1 signaling pathway in cross talk with Mnk1 | journal=Molecular and Cellular Biochemistry | publisher=Springer Science and Business Media LLC | volume=465 | issue=1-2 | date=2019-11-28 | issn=0300-8177 | doi=10.1007/s11010-019-03663-z | pages=13–26}}
* {{cite journal | last1=Majeed | first1=Sheikh Tahir | last2=Batool | first2=Asiya | last3=Majeed | first3=Rabiya | last4=Bhat | first4=Nadiem Nazir | last5=Zargar | first5=Muhammad Afzal | last6=Andrabi | first6=Khurshid Iqbal | title=mTORC1 induces eukaryotic translation initiation factor 4E interaction with TOS-S6 kinase 1 and its activation | journal=Cell Cycle | publisher=Informa UK Limited | volume=20 | issue=9 | date=2021-05-03 | issn=1538-4101 | doi=10.1080/15384101.2021.1901038 | doi-access=free | pages=839–854 | url=https://www.tandfonline.com/doi/pdf/10.1080/15384101.2021.1901038?needAccess=true | access-date=2025-08-16| pmc=8168643 }}
* {{cite journal | last1=Bhat | first1=Nadiem Nazir | last2=Padder | first2=Bilal A. | last3=Barthelson | first3=Roger A. | last4=Andrabi | first4=Khurshid I. | title=Compendium of Colletotrichum graminicola responsive infection-induced transcriptomic shifts in the maize | journal=Plant Gene | publisher=Elsevier BV | volume=17 | year=2019 | issn=2352-4073 | doi=10.1016/j.plgene.2018.11.001 | page=100166}}
* {{cite journal | last1=Iqbal | first1=Mir Khurshid | last2=Zargar | first2=Mohammad Afzal | last3=Mudassar | first3=Syed | last4=Lone | first4=Ghulam Nabi | last5=Yaseen | first5=Syed Besina | last6=Andrabi | first6=Khurshid Iqbal | title=Expression Profiling and Cellular Localization of Stress Responsive Proteins in Squamous Cell Carcinoma of Human Esophagus | journal=Cancer Investigation | publisher=Informa UK Limited | volume=34 | issue=6 | date=2016-06-28 | issn=0735-7907 | doi=10.1080/07357907.2016.1178760 | pages=237–245}}
* {{cite journal | last1=Akther | first1=Nayeema | last2=Andrabi | first2=Khursheed | last3=Nissar | first3=Albeena | last4=Ganaie | first4=Showkat | last5=Chandan | first5=B.K. | last6=Gupta | first6=A.P. | last7=Khuswant | first7=Manoj | last8=Sultana | first8=Sarwat | last9=Shawl | first9=Abdul S. | title=Hepatoprotective activity of LC–ESI-MS standardized Iris spuria rhizome extract on its main bioactive constituents | journal=Phytomedicine | publisher=Elsevier BV | volume=21 | issue=10 | year=2014 | issn=0944-7113 | doi=10.1016/j.phymed.2014.04.007 | pages=1202–1207}}
* {{cite journal | last1=Showkat | first1=Mehvish | last2=Beigh | first2=Mushtaq A. | last3=Bhat | first3=Basharat B. | last4=Batool | first4=Asiya | last5=Andrabi | first5=Khurshid I. | title=Phosphorylation dynamics of eukaryotic initiation factor 4E binding protein 1 (4E-BP1) is discordant with its potential to interact with eukaryotic initiation factor 4E (eIF4E) | journal=Cellular Signalling | publisher=Elsevier BV | volume=26 | issue=10 | year=2014 | issn=0898-6568 | doi=10.1016/j.cellsig.2014.06.008 | pages=2117–2121}}
* {{cite journal | last1=Beigh | first1=Mushtaq Ahmad | last2=Showkat | first2=Mehvish | last3=Bashir | first3=Basharat | last4=Bashir | first4=Asma | last5=Hussain | first5=Mahboob ul | last6=Andrabi | first6=Khurshid Iqbal | title=Growth Inhibition by Bupivacaine Is Associated with Inactivation of Ribosomal Protein S6 Kinase 1 | journal=BioMed Research International | publisher=Wiley | volume=2014 | year=2014 | issn=2314-6133 | doi=10.1155/2014/831845 | doi-access=free | pages=1–9| pmc=3925553 }}
* {{cite journal | last1=Waza | first1=Ajaz Ahmad | last2=Andrabi | first2=Khurshid | last3=Hussain | first3=Mahboob Ul | title=Protein kinase C (PKC) mediated interaction between conexin43 (Cx43) and K+(ATP) channel subunit (Kir6.1) in cardiomyocyte mitochondria: Implications in cytoprotection against hypoxia induced cell apoptosis | journal=Cellular Signalling | publisher=Elsevier BV | volume=26 | issue=9 | year=2014 | issn=0898-6568 | doi=10.1016/j.cellsig.2014.05.002 | pages=1909–1917}}

== References ==
{{reflist}}

[[Category:Living people]]
[[Category:1963 births]]
[[Category:Vice-chancellors of the University of Kashmir]]
[[Category:People from Srinagar]]
[[Category:University of Kashmir alumni]]
[[Category:Indian academics]]
[[Category:People from Jammu and Kashmir]]

Khurshid Iqbal Andrabi - Revision history

WaldoOakes4 at 10:39, 25 March 2026